Delicious Poison: Arsenic Trioxide for the Treatment of Leukemia
Open Access
- 1 May 1997
- journal article
- Published by American Society of Hematology in Blood
- Vol. 89 (9) , 3487
- https://doi.org/10.1182/blood.v89.9.3487
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteinsBlood, 1996
- CHRONIC ARSENICAL POISONING DURING THE TREATMENT OF CHRONIC MYELOID LEUKEMIAArchives of internal medicine (1960), 1937
- THE THERAPEUTIC EFFECT OF SOLUTION OF POTASSIUM ARSENITE IN CHRONIC MYELOGENOUS LEUKEMIAAnnals of Internal Medicine, 1936
- ARSENIC AS A THERAPEUTIC AGENT IN CHRONIC MYELOGENOUS LEUKEMIAJAMA, 1931
- Action of Iron, Cod-liver Oil, and Arsenic on the Globular Richness of the BloodThe Lancet Healthy Longevity, 1878